Heparan Sulfate Proteoglycans (HSPGs) modulate BMP2 osteogenic bioactivity in C2C12 cells

147Citations
Citations of this article
116Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Cell surface heparan sulfate proteoglycans (HSPGs) have been implicated in bone morphogenetic protein (BMP)-mediated morphogenesis by regulating BMP activity and gradient formation. However, the direct role of HSPGs in BMP signaling is poorly understood. Here we show that HSPGs directly regulate BMP2-mediated transdifferentiation of C2C12 myoblasts into osteoblasts. HSPGs sequester BMP2 at the cell surface and mediate BMP2 internalization. Depletion of cell surface HSPGs by heparinase III treatment or decreased glycosaminoglycan chain sulfation with sodium chlorate enhances BMP2 morphogenetic bioactivity. The addition of exogenous heparin, a widely used anticoagulant, reduced BMP2 signaling. Our results suggest that cell surface HSPGs mediate BMP2 internalization and modulate BMP2 osteogenic activity. © 2007 by The American Society for Biochemistry and Molecular Biology, Inc.

Cite

CITATION STYLE

APA

Jiao, X., Billings, P. C., O’Connell, M. P., Kaplan, F. S., Shore, E. M., & Glaser, D. L. (2007). Heparan Sulfate Proteoglycans (HSPGs) modulate BMP2 osteogenic bioactivity in C2C12 cells. Journal of Biological Chemistry, 282(2), 1080–1086. https://doi.org/10.1074/jbc.M513414200

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free